ASML vs MVIS

ASML exhibits strong financial health with a Piotroski F-Score of 4/9, indicating stable fundamentals despite not reaching the 'strong' threshold. The company's robust profitability metrics—especially a 50.46% ROE and 29.42% profit margin—underscore its operational excellence. While the current price of $1,345.69 trades at a premium to both the Graham Number ($193.99) and Intrinsic Value ($507.83), this is justified by exceptional growth prospects and dominant market positioning in semiconductor equipment. The recent earnings beat rate of 50% over the last four quarters and consistent positive surprises support a bullish outlook. The absence of an Altman Z-Score does not indicate distress risk, as the company maintains a low debt-to-equity ratio (0.24) and strong liquidity. Price trades at a 28.2% premium to fair value estimate ($1050.00), limiting near-term upside from a valuation perspective.

MVIS exhibits severe financial distress, highlighted by a critical Piotroski F-Score of 1/9, indicating fundamental weakness across nearly all health metrics. The company is experiencing a catastrophic revenue collapse of -86.50% YoY, coupled with an unsustainable operating margin of -12,541.70%. While the current ratio of 2.69 suggests short-term liquidity, the lack of profitability and a staggering Price/Sales ratio of 164.08 indicate the stock is fundamentally decoupled from its financial reality. The long-term price trend is overwhelmingly negative, with a 5-year decline of 94.3%.